Paul Wachter is Director at Avalanche Biotechnologies, Inc. (AAVL). They have made 5 open-market trades across 2 companies since 2010, most recently 2018-06-14.
CIK 0001504491
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $1.6M since 2010, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TWX | BUY | 2015-08-25 | 2017-02-13 | $69.00 | $897K | +1.3% | +2.8% | +2.6% |
| [AAVL] | SELL · 10b5-1 | 2015-06-15 | 2015-06-17 | $39.86 | $48K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-06-08 | 2015-06-10 | $38.64 | $46K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-06-01 | 2015-06-02 | $36.23 | $43K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-05-26 | 2015-05-27 | $36.95 | $44K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-05-18 | 2015-05-19 | $35.31 | $42K | N/A | N/A | N/A |
| [AAVL] | SELL · 10b5-1 | 2015-05-11 | 2015-05-12 | $33.38 | $40K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-05-04 | 2015-05-06 | $30.87 | $37K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-04-27 | 2015-04-29 | $35.61 | $42K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-04-20 | 2015-04-21 | $40.19 | $48K | N/A | N/A | N/A |
| AAVL | SELL · 10b5-1 | 2015-04-13 | 2015-04-15 | $39.35 | $47K | N/A | N/A | N/A |
| AAVL | SELL | 2015-01-13 | 2015-01-15 | $55.46 | $776K | N/A | N/A | N/A |
| TWX | BUY | 2014-11-12 | 2014-11-13 | $77.88 | $389K | +10.8% | +1.9% | +1.9% |
| TWX | BUY | 2013-08-09 | 2013-08-12 | $64.33 | $193K | +10.8% | +1.9% | +1.9% |
| TWX | BUY | 2010-12-15 | 2011-02-02 | $31.50 | $95K | +10.8% | +1.9% | +1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.